(Q37335667)

19 August 2017

A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults (English)

1 reference

19 August 2017

1 reference

1 reference

5

Nita K Patel

1 reference

19 August 2017

Gabriel J Robbie

1

1 reference

19 August 2017

Ryan Criste

2

1 reference

19 August 2017

William F Dall'acqua

3

1 reference

19 August 2017

Kathryn Jensen

4

1 reference

19 August 2017

Genevieve A Losonsky

6

1 reference

19 August 2017

M Pamela Griffin

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

30 September 2013

1 reference

19 August 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

19 August 2017

57

1 reference

19 August 2017

6147-6153

1 reference

19 August 2017

12

1 reference

Neonatal Fc receptor and IgG-based therapeutics

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

The burden of respiratory syncytial virus infection in young children

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

FcRn: the neonatal Fc receptor comes of age.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Serum IgG, IgM, and IgA levels in ankylosing spondylitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

An Fc receptor structurally related to MHC class I antigens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3837853

Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24080653

12 December 2020

inferred from PubMed ID database lookup

Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24080653

12 December 2020

inferred from PubMed ID database lookup

Isolation and characterization of an Fc receptor from neonatal rat small intestine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24080653

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.01285-13

1 reference

19 August 2017

1 reference

19 August 2017

1 reference